Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Neutrophil Gelatinase-Associated Lipocalin Concentration in Vaginal Fluid: Relation to Bacterial Vaginosis and Vulvovaginal Candidiasis

Texto completo
Autor(es):
Beghini, Joziani [1, 2] ; Giraldo, Paulo C. [2] ; Linhares, Iara M. [1, 3] ; Ledger, William J. [1] ; Witkin, Steven S. [1]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] Weill Cornell Med Coll, Dept Obstet & Gynecol, Div Immunol & Infect Dis, New York, NY 10065 - USA
[2] Univ Estadual Campinas, Dept Gynecol & Obstet, Sao Paulo - Brazil
[3] Univ Sao Paulo, Sch Med, Dept Gynecol & Obstet, Sao Paulo - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: REPRODUCTIVE SCIENCES; v. 22, n. 8, p. 964-968, AUG 2015.
Citações Web of Science: 10
Resumo

Objective: Neutrophil gelatinase-associated lipocalin (NGAL) is a component of innate immunity that prevents iron uptake by microorganisms. We evaluated whether NGAL was present in vaginal fluid and whether concentrations were altered in women with bacterial vaginosis (BV) or vulvovaginal candidiasis (VVC). Methods: Vaginal secretions from 52 women with VVC, 43 with BV, and 77 healthy controls were assayed by enzyme-linked immunosorbent assay for NGAL and for concentrations of l-lactic acid. Results: The median concentration of NGAL in vaginal fluid was significantly higher in control women (561 pg/mL) than in women with BV (402 pg/mL; P = .0116) and lower in women with VVC (741 pg/mL; P = .0017). Median lactic acid levels were similar in controls (0.11 mmol/L) and women with VVC (0.13 mmol/L) and were lower in women with BV (0.02 mmol/L; P < .0001). The NGAL and lactic acid concentrations were highly correlated (P < .0001). Conclusion: A decrease in Lactobacilli and/or lactic acid plus the absence of leukocytes results in lower vaginal NGAL levels that might facilitate the growth of bacteria associated with BV. (AU)

Processo FAPESP: 11/19960-9 - Resposta humoral cérvico-vaginal (IgA secretora) em mulheres que receberam a vacina quadrivalente contra o HPV
Beneficiário:Paulo César Giraldo
Modalidade de apoio: Auxílio à Pesquisa - Regular